drugset
drugset / Trial / NCT04083105

Nitrous Oxide Prior to Intranasal Midazolam for Moderate Dental Sedation in Pediatric Patients

NCT04083105 ↗

Phase 4 Unknown 150 enrolled Children's Hospital Colorado University of Colorado, Denver · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the effectiveness of nitrous oxide/oxygen administration in reducing the discomfort of intranasal midazolam administration for moderate sedation for dental procedures.

Timeline

Start
2019-07-12
Primary completion
2021-07-11
Completion
2021-07-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrous Oxide Other / unclassified 30 % Inhaled
Subject Nitrous Oxide Other / unclassified 70 % Inhaled
Background Midazolam Small molecule — Intranasal

Indications

No indication recorded.